Page last updated: 2024-09-03

4-(2-chlorophenyl)-2-(2-(4-isobutylphenyl)ethyl)-6,9-dimethyl-6h-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine and Eosinophilia

4-(2-chlorophenyl)-2-(2-(4-isobutylphenyl)ethyl)-6,9-dimethyl-6h-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine has been researched along with Eosinophilia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kagoshima, M; Komatsu, H; Okumoto, T; Tomomatsu, N; Yamaguchi, S1

Other Studies

1 other study(ies) available for 4-(2-chlorophenyl)-2-(2-(4-isobutylphenyl)ethyl)-6,9-dimethyl-6h-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine and Eosinophilia

ArticleYear
Effects of Y-24180, a receptor antagonist to platelet-activating factor, on allergic cutaneous eosinophilia in mice.
    Life sciences, 1999, Volume: 64, Issue:11

    Topics: Animals; Azepines; Cytokines; Eosinophilia; Hypersensitivity; Male; Mice; Mice, Inbred BALB C; Platelet Activating Factor; Skin Diseases; Triazoles

1999